Publicaciones en colaboración con investigadores/as de Assistance Publique -Hopitaux De Paris (35)

2023

  1. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 30, pp. 4768-4778

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Pilot study of a European oncology regimen reference library and matching algorithm

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 227-231

2022

  1. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

  2. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    JAMA Neurology, Vol. 79, Núm. 3, pp. 228-243

  3. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

2020

  1. Association between nutritional profiles of foods underlying Nutri-Score front-of-pack labels and mortality: EPIC cohort study in 10 European countries

    The BMJ, Vol. 370

  2. Preliminary Qualitative and Quantitative Evaluation of DESIREE, a Decision Support Platform for the Management of Primary Breast Cancer Patients

    AMIA ... Annual Symposium proceedings. AMIA Symposium, Vol. 2020, pp. 1012-1021

  3. The balance of adult mental health care: Provision of core health versus other types of care in eight European countries

    Epidemiology and Psychiatric Sciences, Vol. 29

2019

  1. Assessment of disease progression in dysferlinopathy: A 1-year cohort study

    Neurology, Vol. 92, Núm. 5, pp. E461-E474

  2. Gathering Real World Evidence Through the Evaluation of Decision History

    Studies in Health Technology and Informatics

  3. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    The Lancet Neurology, Vol. 18, Núm. 12, pp. 1091-1102

  4. Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy

    Brain, Vol. 142, Núm. 9, pp. 2605-2616

2018

  1. Augmenting guideline knowledge with non-compliant clinical decisions: Experience-based decision support

    Smart Innovation, Systems and Technologies

  2. Case-based decision support system for breast cancer management

    International Journal of Computational Intelligence Systems, Vol. 12, Núm. 1, pp. 28-38

  3. Implementing Guideline-Based, Experience-Based, and Case-Based Approaches to Enrich Decision Support for the Management of Breast Cancer Patients in the DESIREE Project

    Studies in Health Technology and Informatics

  4. Soxf factors regulate murine satellite cell self-renewal and function through inhibition of β-catenin activity

    eLife, Vol. 7

  5. Teenage exercise is associated with earlier symptom onset in dysferlinopathy: A retrospective cohort study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 89, Núm. 11, pp. 1224-1226